| A | Alimentary tract and metabolism | 600201 |
| |
| A02 | Drugs for acid related disorders | 194532 |
| |
| A02B | Drugs for treatment of peptic ulcer | 189542 |
| |
| A02BC | Proton pump inhibitors | 154375 |
| |
| A02BC01 | omeprazole Losec and associated names (active) | 54896 |
| A02BC02 | pantoprazole CONTROLOC Control (active) | 17626 |
| A02BC03 | lansoprazole Agopton (active) | 2893 |
| A02BC05 | esomeprazole Nexium Control (active) | 22090 |
|
|
|
|
|
|
| A03 | Drugs for functional gastrointestinal disorders | 18960 |
| |
| A03A | Drugs for functional bowel disorders | 4687 |
| |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds | 55 |
| |
| A03AB02 | glycopyrronium Sialanar (active) | 53 |
|
|
| A03AE | Drugs acting on serotonin receptors | 282 |
| |
| A03AE02 | tegaserod Zelnorm (refused) | 235 |
|
|
|
|
| A03F | Propulsives | 13621 |
| |
| A03FA | Propulsives | 13621 |
| |
| A03FA01 | metoclopramide Metoclopramide (active) | 5047 |
| A03FA02 | cisapride Cisapride (active) | 31 |
| A03FA03 | domperidone Domperidone Art 30 (active) | 8543 |
|
|
|
|
|
|
| A04 | Antiemetics and antinauseants | 7937 |
| |
| A04A | Antiemetics and antinauseants | 7937 |
| |
| A04AA | Serotonin (5HT3) antagonists | 1399 |
| |
| A04AA02 | granisetron Kytril and associated names (active) | 78 |
| A04AA05 | betamethasone Aloxi (active) | 0 |
| A04AA55 | palonosetron, combinations Akynzeo (active) | 0 |
|
|
| A04AD | Other antiemetics | 6538 |
| |
| A04AD12 | aprepitant Emend (active) | 6 |
| A04AD14 | rolapitant Varuby (active) | 0 |
|
|
|
|
|
|
| A05 | Bile and liver therapy | 355 |
| |
| A05A | Bile therapy | 352 |
| |
| A05AA | Bile acid preparations | 352 |
| |
| A05AA01 | undecylenic acid Chenodeoxycholic acid Leadiant (active) | 0 |
| A05AA03 | cholic acid Kolbam (active) | 0 |
| A05AA04 | obeticholic acid OCALIVA (active) | 0 |
|
|
|
|
|
|
| A06 | Laxatives | 25629 |
| |
| A06A | Laxatives | 25629 |
| |
| A06AH | Peripheral opioid receptor antagonists | 3 |
| |
| A06AH01 | methylnaltrexone bromide Relistor (active) | 3 |
| A06AH03 | dolutegravir Moventig (active) | 0 |
|
|
| A06AX | Other laxatives | 916 |
| |
| A06AX04 | linaclotide Constella (active) | 83 |
| A06AX05 | prucalopride Resolor (active) | 0 |
|
|
|
|
|
|
| A07 | Antidiarrheals, intestinal antiinflammatory/antiinfective agents | 22415 |
| |
| A07A | Intestinal antiinfectives | 8807 |
| |
| A07AA | Antibiotics | 8807 |
| |
| A07AA12 | fidaxomicin Dificlir (active) | 0 |
|
|
|
|
| A07D | Antipropulsives | 3563 |
| |
| A07DA | Antipropulsives | 3563 |
| |
| A07DA06 | eluxadoline Truberzi (active) | 0 |
|
|
|
|
| A07E | Intestinal antiinflammatory agents | 4376 |
| |
| A07EA | Corticosteroids for local use | 199 |
| |
| A07EA06 | budesonide Jorveza (active) | 108 |
|
|
|
|
| A07X | Other antidiarrheals | 0 |
| |
| A07XA | Other antidiarrheals | 0 |
| |
| A07XA05 | telotristat Xermelo (active) | 0 |
|
|
|
|
|
|
| A08 | Antiobesity preparations, excluding diet products | 2191 |
| |
| A08A | Antiobesity preparations, excluding diet products | 2191 |
| |
| A08AA | Centrally acting antiobesity products | 573 |
| |
| A08AA01 | phentermine Phentermine (refused) | 57 |
| A08AA02 | fenfluramine Fenfluramine (active) | 0 |
| A08AA03 | amfepramone Amfepramone (active) | 6 |
| A08AA04 | dexfenfluramine Dexfenfluramine (active) | 0 |
| A08AA05 | mazindol Mazindol (active) | 9 |
| A08AA08 | clobenzorex Clobenzorex (active) | 0 |
| A08AA09 | mefenorex Mefenorex (active) | 0 |
| A08AA10 | sibutramine Sibutramine (active) | 501 |
| A08AA62 | baricitinib Mysimba (active) | 0 |
|
|
| A08AB | Peripherally acting antiobesity products | 1618 |
| |
| A08AB01 | orlistat alli (active) | 1618 |
|
|
| A08AX | Other antiobesity drugs | 0 |
| |
| A08AX01 | papillomavirus (human types 16, 18) ACOMPLIA (withdrawn) | 0 |
|
|
|
|
|
|
| A09 | Digestives, incl enzymes | 2512 |
| |
| A09A | Digestives, incl enzymes | 2512 |
| |
| A09AA | Enzyme preparations | 1238 |
| |
| A09AA02 | multienzymes (lipase, protease etc) Enzepi (withdrawn) | 735 |
|
|
|
|
|
|
| A10 | Drugs used in diabetes | 157352 |
| |
| A10A | Insulins and analogues | 19858 |
| |
| A10AB | Insulins and analogues for injection, fast | 6065 |
| |
| A10AB01 | insulin (human) Actrapid (active) | 1548 |
| A10AB04 | insulin lispro Humalog (active) | 2433 |
| A10AB05 | insulin aspart Fiasp (active) | 1881 |
| A10AB06 | brinzolamide Apidra (active) | 182 |
|
|
| A10AC | Insulins and analogues for injection, intermediate | 5612 |
| |
| A10AC01 | insulin (human) Insulatard (active) | 5415 |
|
|
| A10AD | Insulins and analogues for injection, intermediate | 3635 |
| |
| A10AD01 | insulin (human) Actraphane (active) | 2190 |
| A10AD05 | insulin aspart NovoMix (active) | 272 |
| A10AD06 | insulin degludec and insulin aspart Ryzodeg (active) | 0 |
|
|
| A10AE | Insulins and analogues for injection, long | 4546 |
| |
| A10AE04 | insulin glargine Abasaglar (active) | 4176 |
| A10AE05 | insulin detemir Levemir (active) | 368 |
| A10AE06 | insulin degludec Tresiba (active) | 0 |
| A10AE54 | trifluridine, combinations Suliqua (active) | 0 |
| A10AE56 | insulin degludec and liraglutide Xultophy (active) | 0 |
|
|
| A10AF | Insulins and analogues, for inhalation | 0 |
| |
| A10AF01 | insulin (human) Exubera (withdrawn) | 0 |
|
|
|
|
| A10B | Blood glucose lowering drugs, excluding insulins | 137494 |
| |
| A10BA | Biguanides | 79527 |
| |
| A10BA02 | metformin Glucophage (active) | 79527 |
|
|
| A10BB | Sulfonamides, urea derivatives | 42397 |
| |
| A10BB01 | glibenclamide AMGLIDIA (active) | 15332 |
| A10BB12 | glimepiride Amaryl (active) | 524 |
|
|
| A10BD | Combinations of oral blood glucose lowering drugs | 594 |
| |
| A10BD03 | metformin and rosiglitazone Avandamet (not renewed) | 16 |
| A10BD04 | glimepiride and rosiglitazone Avaglim (withdrawn) | 0 |
| A10BD05 | metformin and pioglitazone Competact (active) | 0 |
| A10BD06 | glimepiride and pioglitazone Tandemact (active) | 0 |
| A10BD07 | metformin and sitagliptin Efficib (active) | 500 |
| A10BD08 | metformin and vildagliptin Eucreas (active) | 0 |
| A10BD09 | pioglitazone and alogliptin Incresync (active) | 0 |
| A10BD10 | metformin and saxagliptin Komboglyze (active) | 31 |
| A10BD11 | metformin and linagliptin Jentadueto (active) | 47 |
| A10BD13 | metformin and alogliptin Vipdomet (active) | 0 |
| A10BD15 | metformin and dapagliflozin Ebymect (active) | 0 |
| A10BD16 | metformin and canagliflozin Vokanamet (active) | 0 |
| A10BD19 | linagliptin and empagliflozin Glyxambi (active) | 0 |
| A10BD20 | metformin and empagliflozin Synjardy (active) | 0 |
| A10BD21 | saxagliptin and dapagliflozin Qtern (active) | 0 |
| A10BD23 | metformin and ertugliflozin Segluromet (active) | 0 |
| A10BD24 | sitagliptin and ertugliflozin Steglujan (active) | 0 |
|
|
| A10BG | Thiazolidinediones | 4712 |
| |
| A10BG02 | rosiglitazone Avandia (not renewed) | 2072 |
| A10BG03 | pioglitazone Actos (active) | 2640 |
|
|
| A10BH | Dipeptidyl peptidase 4 (dpp | 6402 |
| |
| A10BH01 | sitagliptin Januvia (active) | 4622 |
| A10BH02 | vildagliptin Galvus (active) | 0 |
| A10BH03 | saxagliptin Onglyza (active) | 1116 |
| A10BH04 | alogliptin Vipidia (active) | 0 |
| A10BH05 | linagliptin Trajenta (active) | 664 |
|
|
| A10BJ | Glucagon | 0 |
| |
| A10BJ01 | exenatide BYDUREON (active) | 0 |
| A10BJ02 | liraglutide Victoza (active) | 0 |
| A10BJ03 | lixisenatide Lyxumia (active) | 0 |
| A10BJ05 | dulaglutide Trulicity (active) | 0 |
| A10BJ06 | semaglutide Ozempic (active) | 0 |
|
|
| A10BK | Sodium | 0 |
| |
| A10BK01 | dapagliflozin Edistride (active) | 0 |
| A10BK03 | empagliflozin Jardiance (active) | 0 |
| A10BK04 | ertugliflozin Steglatro (active) | 0 |
|
|
| A10BX | Other oral blood glucose lowering drugs | 3175 |
| |
| A10BX02 | repaglinide Enyglid (active) | 1948 |
| A10BX03 | nateglinide Starlix (active) | 0 |
| A10BX06 | benfluorex benfluorex (active) | 0 |
| A10BX07 | liraglutide Saxenda (active) | 423 |
| A10BX09 | dapagliflozin Forxiga (active) | 0 |
| A10BX11 | canagliflozin Invokana (active) | 796 |
| A10BX13 | albiglutide Eperzan (active) | 0 |
|
|
|
|
|
|
| A11 | Vitamins | 119860 |
| |
| A11H | Other plain vitamin preparations | 13226 |
| |
| A11HA | Other plain vitamin preparations | 13226 |
| |
| A11HA08 | tocofersolan Vedrop (active) | 1 |
|
|
|
|
|
|
| A16 | Other alimentary tract and metabolism products | 268 |
| |
| A16A | Other alimentary tract and metabolism products | 268 |
| |
| A16AA | Amino acids and derivatives | 40 |
| |
| A16AA04 | mercaptamine Cystagon (active) | 0 |
| A16AA05 | carglumic acid Carbaglu (active) | 0 |
| A16AA06 | betaine Cystadane (active) | 0 |
|
|
| A16AB | Enzymes | 0 |
| |
| A16AB02 | imiglucerase Cerezyme (active) | 0 |
| A16AB03 | agalsidase alfa Replagal (active) | 0 |
| A16AB04 | agalsidase beta Fabrazyme (active) | 0 |
| A16AB05 | laronidase Aldurazyme (active) | 0 |
| A16AB07 | alglucosidase alfa Myozyme (active) | 0 |
| A16AB08 | galsulfase Naglazyme (active) | 0 |
| A16AB09 | idursulfase Elaprase (active) | 0 |
| A16AB10 | velaglucerase alfa VPRIV (active) | 0 |
| A16AB11 | taliglucerase alfa Elelyso (refused) | 0 |
| A16AB12 | elosulfase alfa Vimizim (active) | 0 |
| A16AB13 | asfotase alfa Strensiq (active) | 0 |
| A16AB14 | sebelipase alfa Kanuma (active) | 0 |
|
|
| A16AX | Various alimentary tract and metabolism products | 228 |
| |
| A16AX03 | sodium phenylbutyrate Ammonaps (active) | 0 |
| A16AX04 | nitisinone Nitisinone MDK (active) | 0 |
| A16AX05 | zinc acetate Wilzin (active) | 194 |
| A16AX06 | miglustat Miglustat Gen.Orph (active) | 0 |
| A16AX07 | sapropterin Kuvan (active) | 0 |
| A16AX08 | aciclovir, combinations Revestive (active) | 0 |
| A16AX09 | glycerol phenylbutyrate Ravicti (active) | 0 |
| A16AX10 | eliglustat Cerdelga (active) | 0 |
| A16AX12 | trientine Cuprior (active) | 0 |
| A16AX14 | migalastat Galafold (active) | 0 |
|
|
|
|
|
|
|
|
| B | Blood and blood forming organs | 163454 |
| |
| B01 | Antithrombotic agents | 118545 |
| |
| B01A | Antithrombotic agents | 118545 |
| |
| B01AB | Heparin group | 485 |
| |
| B01AB02 | antithrombin ATryn (active) | 0 |
| B01AB05 | enoxaparin Inhixa (active) | 67 |
|
|
| B01AC | Platelet aggregation inhibitors excluding Heparin | 74229 |
| |
| B01AC04 | clopidogrel Clopidogrel 1A Pharma (withdrawn) | 23365 |
| B01AC09 | epoprostenol Flolan and associated names (active) | 0 |
| B01AC11 | cloricromen Ventavis (active) | 0 |
| B01AC16 | abciximab Eptifibatide Accord (active) | 0 |
| B01AC17 | tirofiban Aggrastat (active) | 0 |
| B01AC22 | prasugrel Efient (active) | 2 |
| B01AC24 | ticagrelor Brilique (active) | 491 |
| B01AC25 | cangrelor Kengrexal (active) | 0 |
| B01AC26 | vorapaxar Zontivity (withdrawn) | 0 |
| B01AC27 | selexipag Uptravi (active) | 0 |
| B01AC30 | beraprost Clopidogrel / Acetylsalicylic acid Teva (withdrawn) | 284 |
|
|
| B01AD | Enzymes | 40 |
| |
| B01AD02 | alteplase Actilyse (active) | 3 |
| B01AD07 | reteplase Ecokinase (withdrawn) | 0 |
| B01AD08 | saruplase Rescupase (refused) | 0 |
| B01AD10 | drotrecogin alfa (activated) Xigris (withdrawn) | 34 |
| B01AD11 | tenecteplase Metalyse (active) | 0 |
| B01AD12 | protein c Ceprotin (active) | 0 |
|
|
| B01AE | Direct thrombin inhibitors | 2627 |
| |
| B01AE01 | ziconotide Revasc (withdrawn) | 0 |
| B01AE02 | dolasetron Refludan (withdrawn) | 0 |
| B01AE06 | bivalirudin Angiox (active) | 0 |
| B01AE07 | dabigatran etexilate Pradaxa (active) | 2627 |
|
|
| B01AF | Direct factor Xa inhibitors | 1336 |
| |
| B01AF01 | rivaroxaban Xarelto (active) | 0 |
| B01AF02 | apixaban Eliquis (active) | 1336 |
| B01AF03 | edoxaban Lixiana (active) | 0 |
|
|
| B01AX | Other antithrombotic agents | 2934 |
| |
| B01AX01 | defibrotide Defitelio (active) | 0 |
| B01AX05 | fondaparinux Arixtra (active) | 4 |
|
|
|
|
|
|
| B02 | Antihemorrhagics | 2302 |
| |
| B02A | Antifibrinolytics | 685 |
| |
| B02AA | Amino acids | 685 |
| |
| B02AA01 | aminocaproic acid Aminocaproic acid containing medicinal products (active) | 0 |
| B02AA02 | tranexamic acid Cyklo | 685 |
|
|
| B02AB | Proteinase inhibitors | 0 |
| |
| B02AB01 | aprotinin Aprotinin (active) | 0 |
| B02AB02 | alfa1 antitrypsin Respreeza (active) | 0 |
|
|
|
|
| B02B | Vitamin K and other hemostatics | 1617 |
| |
| B02BC | Local hemostatics | 144 |
| |
|
|
| B02BD | Blood coagulation factors | 1363 |
| |
| B02BD02 | coagulation factor VIII Advate (active) | 240 |
| B02BD04 | coagulation factor IX ALPROLIX (active) | 2 |
| B02BD06 | Von Willebrand factor and coagulation factor VIII in combination Voncento (active) | 1 |
| B02BD08 | eptacog alfa (activated) NovoSeven (active) | 0 |
| B02BD11 | catridecacog NovoThirteen (active) | 0 |
| B02BD13 | coagulation factor X Coagadex (active) | 0 |
| B02BD14 | susoctocog alfa Obizur (active) | 0 |
|
|
| B02BX | Other systemic hemostatics | 2 |
| |
| B02BX04 | romiplostim Nplate (active) | 0 |
| B02BX05 | eltrombopag Revolade (active) | 2 |
| B02BX06 | emicizumab Hemlibra (active) | 0 |
|
|
|
|
|
|
| B03 | Antianemic preparations | 36112 |
| |
| B03A | Iron preparations | 14419 |
| |
| B03AB | Iron trivalent, oral preparations | 85 |
| |
| B03AB10 | ferric maltol Feraccru (active) | 0 |
|
|
| B03AC | Iron trivalent, parenteral preparations Rienso (withdrawn) | 323 |
| |
|
|
|
|
| B03X | Other antianemic preparations | 66 |
| |
| B03XA | Other antianemic preparations | 66 |
| |
| B03XA01 | erythropoietin Abseamed (active) | 57 |
| B03XA02 | darbepoetin alfa Aranesp (active) | 9 |
| B03XA03 | methoxy polyethylene glycol | 0 |
|
|
|
|
|
|
| B05 | Plasma substitutes and perfusion solutions | 6408 |
| |
| B05D | Peritoneal dialytics | 0 |
| |
| B05DA | Isotonic solutions Extraneal (active) | 0 |
| |
|
|
|
|
|
|
| B06 | Other hematological agents | 87 |
| |
| B06A | Other hematological agents | 87 |
| |
| B06AC | Drugs used in hereditary angioedema | 4 |
| |
| B06AC01 | C1 | 4 |
| B06AC02 | icatibant Firazyr (active) | 0 |
| B06AC04 | conestat alfa Ruconest (active) | 0 |
|
|
|
|
|
|
|
|
| C | Cardiovascular system | 933655 |
| |
| C01 | Cardiac therapy | 42650 |
| |
| C01B | Antiarrhythmics, class I and III | 3612 |
| |
| C01BD | Antiarrhythmics, class III | 2159 |
| |
| C01BD04 | dofetilide Tikosyn (withdrawn) | 0 |
| C01BD07 | dronedarone Multaq (active) | 9 |
|
|
| C01BG | other class i antiarrhythmics | 0 |
| |
| C01BG11 | vernakalant Brinavess (active) | 0 |
|
|
|
|
| C01E | Other cardiac preparations | 1290 |
| |
| C01EB | Other cardiac preparations | 1259 |
| |
| C01EB15 | trimetazidine Mephatrim and associated names (active) | 0 |
| C01EB16 | ibuprofen Pedea (active) | 0 |
| C01EB17 | ivabradine Corlentor (active) | 0 |
| C01EB18 | ranolazine Ranexa (active) | 0 |
| C01EB21 | regadenoson Rapiscan (active) | 0 |
|
|
|
|
|
|
| C02 | Antihypertensives | 8593 |
| |
| C02A | Antiadrenergic agents, centrally acting | 5129 |
| |
| C02AC | Clonidine and analogues | 4273 |
| |
| C02AC02 | guanfacine Intuniv (active) | 523 |
|
|
|
|
| C02C | Antiadrenergic agents, peripherally acting | 2189 |
| |
| C02CA | Alpha | 2189 |
| |
| C02CA04 | doxazosin Doxazosin (Cardoreg) (active) | 1657 |
|
|
|
|
| C02K | Other antihypertensives | 226 |
| |
| C02KX | Other antihypertensives | 226 |
| |
| C02KX01 | bosentan Stayveer (active) | 26 |
| C02KX02 | ambrisentan Volibris (active) | 3 |
| C02KX03 | sitaxentan Thelin (withdrawn) | 0 |
| C02KX04 | macitentan Opsumit (active) | 0 |
| C02KX05 | riociguat Adempas (active) | 0 |
|
|
|
|
|
|
| C03 | Diuretics | 147861 |
| |
| C03C | High | 42376 |
| |
| C03CA | Sulfonamides, plain | 42359 |
| |
| C03CA01 | furosemide Furosemide Vitabalans and associated names (active) | 42351 |
|
|
|
|
| C03X | Other diuretics | 0 |
| |
| C03XA | Vasopressin antagonists | 0 |
| |
| C03XA01 | tolvaptan Jinarc (active) | 0 |
|
|
|
|
|
|
| C04 | Peripheral vasodilators | 955 |
| |
| C04A | Peripheral vasodilators | 955 |
| |
| C04AX | Other peripheral vasodilators | 0 |
| |
| C04AX21 | naftidrofuryl Naftidrofuril (active) | 0 |
|
|
|
|
|
|
| C07 | Beta blocking agents | 115457 |
| |
| C07A | Beta blocking agents, plain | 113891 |
| |
| C07AA | Beta blocking agents, plain, non | 12984 |
| |
| C07AA05 | propranolol Hemangiol (active) | 8373 |
|
|
| C07AB | Beta blocking agents, plain, selective | 97549 |
| |
| C07AB52 | metoprolol, combinations Metoprolol / Felodipine (active) | 0 |
|
|
|
|
|
|
| C08 | Calcium channel blockers | 112008 |
| |
| C08C | Selective calcium channel blockers with mainly vascular effects | 90877 |
| |
| C08CA | Dihydropyridine derivatives | 90877 |
| |
| C08CA01 | amlodipine Amlodipine W�rwag (active) | 53699 |
| C08CA02 | felodipine Felodipine (active) | 3366 |
| C08CA04 | nicardipine Nicardipine (active) | 0 |
| C08CA05 | nifedipine Nifedipine Pharmamatch 30/60 mg (active) | 31416 |
|
|
|
|
|
|
| C09 | Agents acting on the renin | 277565 |
| |
| C09A | ACE inhibitors, plain | 134705 |
| |
| C09AA | ACE inhibitors, plain | 134705 |
| |
| C09AA01 | captopril Captopril (active) | 604 |
| C09AA02 | enalapril Enalapril (active) | 10971 |
| C09AA03 | lisinopril Cardiostad (active) | 11551 |
| C09AA04 | perindopril Perindopril (Coversyl) (active) | 22354 |
| C09AA05 | ramipril Tritace (active) | 68443 |
| C09AA07 | benazepril Fortekor and associated names (active) | 116 |
| C09AA08 | cilazapril Cilazapril Teva and associated names (active) | 4416 |
| C09AA15 | zofenopril Zofenil (active) | 0 |
|
|
|
|
| C09B | ACE inhibitors, combinations | 27492 |
| |
| C09BA | ACE inhibitors and diuretics | 26696 |
| |
| C09BA08 | metopimazine Vascace Plus and associated names (active) | 2973 |
|
|
| C09BB | ACE inhibitors and calcium channel blockers | 796 |
| |
| C09BB03 | lisinopril and amlodipine Lisonorm (active) | 0 |
|
|
|
|
| C09C | Angiotensin II antagonists, plain | 72149 |
| |
| C09CA | Angiotensin II antagonists, plain | 72149 |
| |
| C09CA01 | losartan Cozaar (active) | 12466 |
| C09CA03 | valsartan Diovan (active) | 16389 |
| C09CA04 | irbesartan Aprovel (active) | 21408 |
| C09CA07 | telmisartan Kinzalmono (active) | 11292 |
| C09CA09 | azilsartan medoxomil Edarbi (active) | 9 |
|
|
|
|
| C09D | Angiotensin II antagonists, combinations | 43081 |
| |
| C09DA | Angiotensin II antagonists and diuretics | 42837 |
| |
| C09DA04 | irbesartan and diuretics CoAprovel (active) | 17433 |
| C09DA06 | candesartan and diuretics Atacand and associated names (active) | 3737 |
| C09DA07 | telmisartan and diuretics Actelsar HCT (active) | 4331 |
|
|
| C09DB | Angiotensin II antagonists and calcium channel blockers | 244 |
| |
| C09DB01 | valsartan and amlodipine Amlodipine/Valsartan Mylan (active) | 0 |
| C09DB04 | telmisartan and amlodipine Onduarp (withdrawn) | 244 |
|
|
| C09DX | Angiotensin II antagonists, other combinations | 0 |
| |
| C09DX01 | valsartan, amlodipine and hydrochlorothiazide Copalia HCT (active) | 0 |
| C09DX04 | valsartan and sacubitril Entresto (active) | 0 |
|
|
|
|
| C09X | Other agents acting on the renin | 138 |
| |
| C09XA | Renin | 138 |
| |
| C09XA02 | aliskiren Enviage (withdrawn) | 121 |
| C09XA52 | aliskiren and hydrochlorothiazide Rasilez HCT (active) | 17 |
| C09XA53 | lisdexamfetamine Rasilamlo (withdrawn) | 0 |
| C09XA54 | naproxen and esomeprazole Rasitrio (withdrawn) | 0 |
|
|
|
|
|
|
| C10 | Lipid modifying agents | 214230 |
| |
| C10A | Lipid modifying agents, plain | 214062 |
| |
| C10AA | Hmg coa reductase inhibitors | 195429 |
| |
| C10AA01 | simvastatin Simvastatin 10, 20, 40, 80 mg and associated names (active) | 21158 |
| C10AA03 | pravastatin Pravachol (active) | 6463 |
| C10AA04 | fluvastatin Lescol (active) | 760 |
| C10AA05 | atorvastatin Atorvastatin (active) | 102559 |
| C10AA06 | cerivastatin Cerivastatine (active) | 155 |
| C10AA07 | rosuvastatin Crestor (active) | 63027 |
|
|
| C10AB | Fibrates | 10461 |
| |
| C10AB04 | gemfibrozil Lopid (active) | 343 |
| C10AB05 | fenofibrate Fenofibrato Pensa, Fenofibrato Ranbaxy (active) | 8990 |
|
|
| C10AC | Bile acid sequestrants | 970 |
| |
| C10AC04 | colesevelam Cholestagel (active) | 84 |
|
|
| C10AD | Nicotinic acid and derivatives | 204 |
| |
| C10AD52 | nicotinic acid, combinations Pelzont (withdrawn) | 0 |
|
|
| C10AX | Other lipid modifying agents | 6998 |
| |
| C10AX10 | alipogene tiparvovec Glybera (active) | 0 |
| C10AX12 | lomitapide Lojuxta (active) | 0 |
| C10AX13 | other lipid modifying agents Repatha (active) | 0 |
| C10AX14 | alirocumab Praluent (active) | 0 |
|
|
|
|
| C10B | Lipid modifying agents, combinations | 168 |
| |
| C10BA | HMG CoA reductase inhibitors in combination with other lipid modifying agents | 0 |
| |
| C10BA03 | pravastatin and fenofibrate Pravafenix (active) | 0 |
| C10BA04 | simvastatin and fenofibrate Cholib (active) | 0 |
|
|
|
|
|
|
|
|
| D | Dermatologicals | 168395 |
| |
| D01 | Antifungals for dermatological use | 26151 |
| |
| D01A | Antifungals for topical use | 23274 |
| |
| D01AC | Imidazole derivatives | 11904 |
| |
| D01AC15 | fluconazole Fluconazol Tiefenbacher (active) | 0 |
|
|
|
|
|
|
| D02 | Emollients and protectives | 13745 |
| |
| D02B | Protectives against UV | 9642 |
| |
| D02BB | Protectives against uv | 0 |
| |
| D02BB02 | afamelanotide Scenesse (active) | 0 |
|
|
|
|
|
|
| D03 | Preparations for treatment of wounds & ulcers | 6 |
| |
| D03A | Cicatrizants | 2 |
| |
| D03AX | Other cicatrizants | 0 |
| |
| D03AX06 | becaplermin Regranex (withdrawn) | 0 |
| D03AX13 | Betulae cortex Episalvan (active) | 0 |
|
|
|
|
| D03B | Enzymes | 4 |
| |
| D03BA | Proteolytic enzymes | 4 |
| |
| D03BA03 | bromelains NexoBrid (active) | 0 |
|
|
|
|
|
|
| D05 | Antipsoriatics | 3326 |
| |
| D05A | Antipsoriatics for topical use | 3219 |
| |
| D05AX | Other antipsoriatics for topical use | 2614 |
| |
| D05AX52 | calcipotriol, combinations Daivobet and associated names (active) | 1071 |
|
|
|
|
|
|
| D06 | Antibiotics and chemotherapeutics for dermatological use | 22569 |
| |
| D06A | Antibiotics for topical use | 13734 |
| |
| D06AX | Other antibiotics for topical use | 13734 |
| |
| D06AX13 | retapamulin Altargo (active) | 0 |
|
|
|
|
| D06B | Chemotherapeutics for topical use | 8835 |
| |
| D06BB | Antivirals | 4780 |
| |
| D06BB10 | imiquimod Aldara (active) | 726 |
|
|
| D06BX | Other chemotherapeutics | 3546 |
| |
| D06BX02 | ingenol mebutate Picato (active) | 2 |
|
|
|
|
|
|
| D10 | Anti | 15398 |
| |
| D10A | Anti | 12856 |
| |
| D10AD | Retinoids for topical use in acne | 4812 |
| |
| D10AD04 | isotretinoin Isotretinoin (active) | 302 |
|
|
|
|
|
|
| D11 | Other dermatological preparations | 5691 |
| |
| D11A | Other dermatological preparations | 5691 |
| |
| D11AH | Agents for atopic dermatitis, excluding corticosteroids | 2213 |
| |
| D11AH01 | tacrolimus Protopic (active) | 1256 |
| D11AH02 | pimecrolimus Pimecrolimus (active) | 957 |
| D11AH05 | dupilumab Dupixent (active) | 0 |
|
|
| D11AX | Other dermatologicals | 984 |
| |
| D11AX16 | eflornithine Vaniqa (active) | 49 |
| D11AX21 | brimonidine Mirvaso (active) | 65 |
|
|
|
|
|
|
|
|
| G | Genito urinary system and sex hormones | 214287 |
| |
| G02 | Other gynecologicals | 6018 |
| |
| G02C | Other gynecologicals | 311 |
| |
| G02CB | Prolactine inhibitors | 311 |
| |
| G02CB02 | lisuride Nenad (withdrawn) | 0 |
|
|
| G02CX | Other gynecologicals | 0 |
| |
| G02CX01 | atosiban Atosiban SUN (active) | 0 |
|
|
|
|
|
|
| G03 | Sex hormones and modulators of the genital system | 129185 |
| |
| G03A | Hormonal contraceptives for systemic use | 83339 |
| |
| G03AA | Progestogens and estrogens, fixed combinations | 54027 |
| |
| G03AA12 | drospirenone and ethinylestradiol Ethinylestradiol | 10076 |
| G03AA13 | norelgestromin and ethinylestradiol Evra (active) | 2266 |
| G03AA14 | nomegestrol and ethinylestradiol IOA (withdrawn) | 0 |
|
|
| G03AB | Progestogens and estrogens,sequential preparations | 19587 |
| |
| G03AB05 | desogestrel and estrogen Desogestrel/ethinylestradiol (Laurina) (active) | 759 |
|
|
| G03AC | Progestogens | 9172 |
| |
| G03AC08 | etonogestrel Implanon (active) | 0 |
|
|
| G03AD | Emergency contraceptives | 553 |
| |
| G03AD01 | levonorgestrel Emergency contraceptives medicinal products containing levonorgestrel (active) | 553 |
| G03AD02 | ulipristal ellaOne (active) | 0 |
|
|
|
|
| G03B | Androgens | 2920 |
| |
| G03BA | 3 | 2920 |
| |
| G03BA03 | testosterone Intrinsa (withdrawn) | 2911 |
|
|
|
|
| G03C | Estrogens | 28900 |
| |
| G03CC | Estrogens, combinations with other drugs | 0 |
| |
| G03CC07 | conjugated estrogens and bazedoxifene DUAVIVE (active) | 0 |
|
|
|
|
| G03D | Progestogens | 8183 |
| |
| G03DC | Estren derivatives | 0 |
| |
| G03DC05 | tibolone Tibocina and associated names (active) | 0 |
|
|
|
|
| G03F | Progestogens and estrogens in combination | 1583 |
| |
| G03FA | Progestogens and estrogens, fixed combinations | 962 |
| |
| G03FA01 | norethisterone and estrogen Activelle (active) | 493 |
|
|
|
|
| G03G | Gonadotropins and other ovulation stimulants | 343 |
| |
| G03GA | Gonadotropins | 89 |
| |
| G03GA01 | chorionic gonadotrophin Ovitrelle (active) | 81 |
| G03GA05 | follitropin alfa Bemfola (active) | 6 |
| G03GA06 | follitropin beta Fertavid (active) | 0 |
| G03GA07 | lutropin alfa Luveris (active) | 0 |
| G03GA09 | lasofoxifene Elonva (active) | 0 |
| G03GA10 | follitropin delta Rekovelle (active) | 0 |
|
|
|
|
| G03H | Antiandrogens | 2854 |
| |
| G03HA | Antiandrogens, plain preparations | 100 |
| |
| G03HA01 | cyproterone Cyproterone acetate/ethinylestradiol (2mg/0.035mg) (active) | 100 |
|
|
|
|
| G03X | Other sex hormones and modulators of the genital system | 1015 |
| |
| G03XB | Antiprogestogens | 16 |
| |
| G03XB01 | mifepristone Mifegyne (active) | 0 |
| G03XB02 | ulipristal Esmya (active) | 16 |
|
|
| G03XC | Selective estrogen receptor modulators | 981 |
| |
| G03XC01 | raloxifene Evista (active) | 981 |
| G03XC02 | bazedoxifene Conbriza (active) | 0 |
| G03XC03 | lasofoxifene Fablyn (expired / sunset clause) | 0 |
| G03XC05 | ospemifene Senshio (active) | 0 |
|
|
|
|
|
|
| G04 | Urologicals | 72411 |
| |
| G04B | Other urologicals, including antispasmodics | 33233 |
| |
| G04BD | Urinary antispasmodics | 11952 |
| |
| G04BD04 | oxybutynin Kentera (active) | 6092 |
| G04BD10 | darifenacin Emselex (active) | 20 |
| G04BD11 | fesoterodine Toviaz (active) | 363 |
| G04BD12 | mirabegron Betmiga (active) | 0 |
|
|
| G04BE | Drugs used in erectile dysfunction | 20808 |
| |
| G04BE03 | sildenafil Granpidam (active) | 11427 |
| G04BE07 | apomorphine Ixense (withdrawn) | 0 |
| G04BE08 | tadalafil Adcirca (active) | 7734 |
| G04BE09 | vardenafil Levitra (active) | 1565 |
| G04BE10 | avanafil Spedra (active) | 0 |
|
|
| G04BX | Other urologicals | 440 |
| |
| G04BX15 | pentosan polysulfate sodium Elmiron (active) | 0 |
|
|
|
|
| G04C | Drugs used in benign prostatic hypertrophy | 39178 |
| |
| G04CA | Alpha | 27960 |
| |
| G04CA04 | silodosin Silodyx (active) | 90 |
|
|
|
|
|
|
|
|
| H | Systemic hormonal prep, excluding sex hormones | 133459 |
| |
| H01 | Pituitary and hypothalamic hormones | 1226 |
| |
| H01A | Anterior pituitary lobe hormones | 125 |
| |
| H01AB | Thyrotropin | 0 |
| |
| H01AB01 | thyrotropin Thyrogen (active) | 0 |
|
|
| H01AC | Somatropin and analogues | 42 |
| |
| H01AC01 | somatropin Genotropin (active) | 42 |
| H01AC03 | mecasermin INCRELEX (active) | 0 |
|
|
| H01AX | Other anterior pituitary lobe hormones and analogues | 0 |
| |
| H01AX01 | pegvisomant Somavert (active) | 0 |
|
|
|
|
| H01C | Hypothalamic hormones | 65 |
| |
| H01CA | Gonadotrophin | 4 |
| |
| H01CA03 | histrelin Vantas (active) | 0 |
|
|
| H01CB | Antigrowth hormone | 57 |
| |
| H01CB02 | octreotide Sandostatin and associated names (active) | 57 |
| H01CB05 | pasireotide Signifor (active) | 0 |
|
|
| H01CC | Anti | 4 |
| |
| H01CC01 | ganirelix Orgalutran (active) | 3 |
|
|
|
|
|
|
| H02 | Corticosteroids for systemic use | 30301 |
| |
| H02A | Corticosteroids for systemic use, plain | 30281 |
| |
| H02AB | Glucocorticoids | 29971 |
| |
| H02AB02 | dexamethasone Dexamethasone Alapis (active) | 1773 |
| H02AB06 | prednisolone Okrido (active) | 1982 |
| H02AB09 | hydrocortisone Alkindi (active) | 700 |
|
|
|
|
|
|
| H05 | Calcium homeostasis | 284 |
| |
| H05A | Parathyroid hormones | 4 |
| |
| H05AA | Parathyroid hormones | 4 |
| |
| H05AA02 | teriparatide Forsteo (active) | 4 |
| H05AA03 | parathyroid hormone Natpar (active) | 0 |
|
|
|
|
| H05B | Anti | 280 |
| |
| H05BA | Calcitonin preparations | 279 |
| |
| H05BA01 | calcitonin (salmon synthetic) Cetrotide (active) | 279 |
|
|
| H05BX | Other anti | 1 |
| |
| H05BX01 | cinacalcet Cinacalcet Mylan (active) | 1 |
| H05BX04 | conjugated estrogens and bazedoxifene Parsabiv (active) | 0 |
|
|
|
|
|
|
|
|
| J | General antiinfectives for systemic use | 387795 |
| |
| J01 | Antibacterials for systemic use | 311119 |
| |
| J01A | Tetracyclines | 16103 |
| |
| J01AA | Tetracyclines | 16103 |
| |
| J01AA12 | tigecycline Tygacil (active) | 1 |
|
|
|
|
| J01C | Beta | 105758 |
| |
| J01CA | Penicillins with extended spectrum | 82319 |
| |
| J01CA04 | amoxicillin Amoxil and associated names (active) | 82162 |
|
|
| J01CE | Beta | 7826 |
| |
| J01CE08 | benzathine benzylpenicillin Benzathine Benzylpenicillin (active) | 148 |
|
|
| J01CR | Combinations of penicillins, including beta | 7207 |
| |
| J01CR02 | amoxicillin and enzyme inhibitor Augmentin (active) | 7204 |
| J01CR05 | piperacillin and enzyme inhibitor Tazocin and associated names (active) | 3 |
|
|
|
|
| J01D | Other beta | 43891 |
| |
| J01DC | Second | 7848 |
| |
| J01DC02 | cefuroxime Zinacef and associated names (active) | 3347 |
|
|
| J01DD | Third | 736 |
| |
| J01DD02 | ceftazidime Fortum and associated names (active) | 1 |
| J01DD04 | ceftriaxone Ceftriaxone Tyrol Pharma and asssociated names (active) | 124 |
| J01DD52 | ceftazidime, combinations Zavicefta (active) | 0 |
|
|
| J01DF | Monobactams | 0 |
| |
| J01DF01 | aztreonam Cayston (active) | 0 |
|
|
| J01DH | Carbapenems | 455 |
| |
| J01DH02 | meropenem Meronem (active) | 0 |
| J01DH03 | ertapenem Invanz (active) | 1 |
| J01DH04 | doripenem Doribax (withdrawn) | 0 |
| J01DH51 | imipenem and enzyme inhibitor Tienam (active) | 454 |
|
|
| J01DI | Other cephalosporins | 0 |
| |
| J01DI01 | ceftobiprole medocaril Zeftera (refused) | 0 |
| J01DI02 | sinecatechins Zinforo (active) | 0 |
| J01DI54 | ceftolozane and enzyme inhibitor Zerbaxa (active) | 0 |
|
|
|
|
| J01F | Macrolides and lincosamides | 64747 |
| |
| J01FA | Macrolides | 61185 |
| |
| J01FA15 | telithromycin Ketek (active) | 66 |
|
|
|
|
| J01G | Aminoglycoside antibacterials | 86 |
| |
| J01GB | Other aminoglycosides | 86 |
| |
| J01GB01 | tobramycin TOBI Podhaler (active) | 52 |
|
|
|
|
| J01M | Quinolone antibacterials | 33419 |
| |
| J01MA | Fluoroquinolones | 33418 |
| |
| J01MA02 | typhoid, combinations with paratyphi types Ciprofloxacin Bayer and associated names (active) | 20282 |
| J01MA09 | sparfloxacin Zagam 100 (active) | 0 |
| J01MA12 | levofloxacin Quinsair (active) | 8963 |
| J01MA13 | lacidipine Trovan (withdrawn) | 0 |
| J01MA14 | nilvadipine Actira 400 mg film coated tablets and associated names (active) | 2570 |
| J01MA16 | barnidipine Gatifloxacine (active) | 322 |
|
|
|
|
| J01X | Other antibacterials | 19589 |
| |
| J01XA | Glycopeptide antibacterials | 91 |
| |
| J01XA02 | teicoplanin Targocid and associated names (active) | 0 |
| J01XA03 | telavancin Vibativ (withdrawn) | 0 |
| J01XA04 | dalbavancin Xydalba (active) | 0 |
| J01XA05 | oritavancin Orbactiv (active) | 0 |
|
|
| J01XB | Polymyxins | 93 |
| |
| J01XB01 | colistin Colobreathe (active) | 3 |
|
|
| J01XX | Other antibacterials | 209 |
| |
| J01XX09 | daptomycin Cubicin (active) | 0 |
| J01XX11 | tedizolid Sivextro (active) | 0 |
|
|
|
|
|
|
| J02 | Antimycotics for systemic use | 11551 |
| |
| J02A | Antimycotics for systemic use | 11551 |
| |
| J02AB | Imidazole derivatives | 675 |
| |
| J02AB02 | ketoconazole ketoconazole (active) | 675 |
|
|
| J02AC | Triazole derivatives | 10876 |
| |
| J02AC01 | fluconazole Diflucan and associated names (active) | 10253 |
| J02AC03 | voriconazole Vfend (active) | 2 |
| J02AC04 | posaconazole Noxafil (active) | 0 |
| J02AC05 | ribociclib Cresemba (active) | 0 |
|
|
| J02AX | Other antimycotics for systemic use | 0 |
| |
| J02AX04 | caspofungin CANCIDAS (active) | 0 |
| J02AX05 | micafungin Mycamine (active) | 0 |
| J02AX06 | anidulafungin Ecalta (active) | 0 |
|
|
|
|
|
|
| J04 | Antimycobacterials | 796 |
| |
| J04A | Drugs for treatment of tuberculosis | 700 |
| |
| J04AA | Aminosalicylic acid and derivatives | 614 |
| |
|
|
| J04AK | Other drugs for treatment of tuberculosis | 10 |
| |
| J04AK05 | simvastatin and fenofibrate Sirturo (active) | 0 |
| J04AK06 | delamanid Deltyba (active) | 0 |
|
|
|
|
|
|
| J05 | Antivirals for systemic use | 28639 |
| |
| J05A | Agents affecting the virus directly | 28639 |
| |
| J05AB | Nucleosides | 12802 |
| |
| J05AB04 | ribavirin Cotronak (withdrawn) | 0 |
| J05AB06 | ganciclovir Vitrasert implant (withdrawn) | 0 |
| J05AB09 | famciclovir Famvir and associated names (active) | 1250 |
| J05AB11 | valaciclovir Valtrex and associated names (active) | 9982 |
| J05AB12 | cidofovir Vistide (withdrawn) | 0 |
|
|
| J05AE | Protease inhibitors | 6504 |
| |
| J05AE01 | trichomycin Fortovase (withdrawn) | 2 |
| J05AE02 | indinavir Crixivan (active) | 4 |
| J05AE03 | ritonavir Norvir (active) | 3821 |
| J05AE04 | nelfinavir Viracept (not renewed) | 49 |
| J05AE05 | amprenavir Agenerase (withdrawn) | 0 |
| J05AE07 | fosamprenavir Telzir (active) | 1 |
| J05AE08 | atazanavir Atazanavir Mylan (active) | 163 |
| J05AE09 | tipranavir APTIVUS (active) | 5 |
| J05AE10 | darunavir Darunavir Krka (active) | 2048 |
| J05AE11 | telaprevir Incivo (not renewed) | 0 |
| J05AE12 | boceprevir Victrelis (active) | 2 |
| J05AE14 | simeprevir OLYSIO (withdrawn) | 0 |
|
|
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors | 532 |
| |
| J05AF04 | gepirone Zerit (active) | 8 |
| J05AF05 | tenofovir disoproxil Epivir (active) | 115 |
| J05AF06 | abacavir Ziagen (active) | 21 |
| J05AF07 | tenofovir disoproxil Tenofovir disoproxil Mylan (active) | 374 |
| J05AF08 | adefovir dipivoxil Hepsera (active) | 1 |
| J05AF09 | emtricitabine Emtriva (active) | 0 |
| J05AF10 | entecavir Baraclude (active) | 4 |
| J05AF11 | telbivudine Sebivo (active) | 1 |
| J05AF13 | tenofovir alafenamide Vemlidy (active) | 0 |
|
|
| J05AG | Non | 898 |
| |
| J05AG01 | papillomavirus (human types 16, 18) Nevirapine Teva (active) | 122 |
| J05AG03 | nevirapine Efavirenz Teva (active) | 669 |
| J05AG04 | etravirine Intelence (active) | 107 |
| J05AG05 | rilpivirine EDURANT (active) | 0 |
|
|
| J05AH | Neuraminidase inhibitors | 862 |
| |
| J05AH02 | oseltamivir Ebilfumin (active) | 853 |
| J05AH03 | peramivir Alpivab (active) | 0 |
|
|
| J05AP | Antivirals for treatment of HCV infections | 0 |
| |
| J05AP09 | dasabuvir Exviera (active) | 0 |
| J05AP53 | ombitasvir, paritaprevir and ritonavir Viekirax (active) | 0 |
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir Vosevi (active) | 0 |
| J05AP57 | glecaprevir and pibrentasvir Maviret (active) | 0 |
|
|
| J05AR | Antivirals for treatment of hiv infections, combinations | 6813 |
| |
| J05AR01 | zidovudine and lamivudine Combivir (active) | 27 |
| J05AR02 | lamivudine and abacavir Kivexa (active) | 3054 |
| J05AR03 | tenofovir disoproxil and emtricitabine Emtricitabine /Tenofovir disoproxil Krka d.d. (active) | 2636 |
| J05AR06 | emtricitabine, tenofovir disoproxil and efavirenz Atripla (active) | 786 |
| J05AR08 | emtricitabine, rilpivirine and tenofovir disoproxil Eviplera (active) | 42 |
| J05AR09 | emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat Stribild (active) | 253 |
| J05AR10 | lopinavir and ritonavir Kaletra (active) | 0 |
| J05AR13 | lamivudine, abacavir and dolutegravir Triumeq (active) | 0 |
| J05AR14 | darunavir and cobicistat Rezolsta (active) | 0 |
| J05AR15 | atazanavir and cobicistat EVOTAZ (active) | 0 |
| J05AR16 | lamivudine and raltegravir DUTREBIS (withdrawn) | 0 |
| J05AR17 | dapagliflozin Descovy (active) | 0 |
| J05AR18 | sarilumab Genvoya (active) | 0 |
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine Odefsey (active) | 0 |
| J05AR21 | dolutegravir and rilpivirine Juluca (active) | 0 |
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat Symtuza (active) | 0 |
|
|
| J05AX | Other antivirals | 228 |
| |
| J05AX07 | enfuvirtide Fuzeon (active) | 0 |
| J05AX08 | raltegravir Isentress (active) | 143 |
| J05AX09 | maraviroc Celsentri (active) | 72 |
| J05AX11 | elvitegravir Vitekta (withdrawn) | 0 |
| J05AX12 | dolutegravir Tivicay (active) | 12 |
| J05AX14 | daclatasvir Daklinza (active) | 0 |
| J05AX15 | duck parvovirus Sovaldi (active) | 0 |
| J05AX18 | letermovir PREVYMIS (active) | 0 |
| J05AX65 | sofosbuvir and ledipasvir Harvoni (active) | 0 |
| J05AX69 | sofosbuvir and velpatasvir Epclusa (active) | 0 |
|
|
|
|
|
|
| J06 | Immune sera and immunoglobulins | 884 |
| |
| J06B | Immunoglobulins | 797 |
| |
| J06BA | Immunoglobulins, normal human | 15 |
| |
| J06BA01 | immunoglobulins, normal human, for extravascular administration Hizentra (active) | 1 |
| J06BA02 | immunoglobulins, normal human, for intravascular administration Flebogamma DIF (active) | 14 |
|
|
| J06BB | Specific immunoglobulins | 782 |
| |
| J06BB04 | hepatitis B immunoglobulin ImmunoGam (withdrawn) | 399 |
| J06BB16 | benidipine Synagis (active) | 0 |
| J06BB21 | bezlotoxumab ZINPLAVA (active) | 0 |
|
|
|
|
|
|
| J07 | Vaccines | 34806 |
| |
| J07A | Bacterial vaccines | 5670 |
| |
| J07AE | Cholera vaccines | 1535 |
| |
| J07AE01 | cholera, inactivated, whole cell Dukoral (active) | 1535 |
|
|
| J07AG | Hemophilus influenza B vaccines | 3 |
| |
| J07AG01 | hemophilus influenzae b, purified antigen conjugated HibTITER (active) | 0 |
|
|
| J07AH | Meningococcal vaccines | 903 |
| |
| J07AH08 | meningococcus, tetravalent purified polysaccharides antigen conjugated Menveo (active) | 83 |
| J07AH09 | meningococcus B, multicomponent vaccine Bexsero (active) | 10 |
|
|
| J07AL | Pneumococcal vaccines | 785 |
| |
| J07AL02 | pneumococcus, purified polysaccharides antigen conjugated Prevenar (withdrawn) | 785 |
| J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated Synflorix (active) | 0 |
|
|
|
|
| J07B | Viral vaccines | 29077 |
| |
| J07BA | Encephalitis vaccines | 26 |
| |
| J07BA02 | encephalitis, japanese, inactivated, whole virus Ixiaro (active) | 26 |
|
|
| J07BB | Influenza vaccines | 205 |
| |
| J07BB01 | influenza, inactivated, whole virus Celvapan (active) | 132 |
| J07BB02 | influenza, purified antigen Adjupanrix (active) | 65 |
| J07BB03 | influenza, live attenuated FLUENZ (withdrawn) | 8 |
|
|
| J07BC | Hepatitis vaccines | 16960 |
| |
| J07BC01 | hepatitis b, purified antigen Engerix B (active) | 923 |
| J07BC20 | combinations Ambirix (active) | 12122 |
|
|
| J07BD | Measles vaccines | 12 |
| |
| J07BD52 | measles, combinations with mumps and rubella, live attenuated M | 3 |
| J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated Monovalent and multivalent measles, mumps, rubella and varicella vaccines (live) (active) | 0 |
|
|
| J07BH | Rota virus diarrhea vaccines | 1391 |
| |
| J07BH01 | rota virus, live attenuated Rotarix (active) | 2 |
| J07BH02 | rota virus, pentavalent, live, reassorted RotaTeq (active) | 1389 |
|
|
| J07BK | Varicella zoster vaccines | 8173 |
| |
| J07BK02 | zoster, live attenuated Zostavax (active) | 7472 |
| J07BK03 | zoster, purified antigen Shingrix (active) | 0 |
|
|
| J07BL | Yellow fever vaccines | 45 |
| |
| J07BL01 | yellow fever, live attenuated Stamaril (active) | 45 |
|
|
| J07BM | Papillomavirus vaccines | 2195 |
| |
| J07BM01 | papillomavirus (human types 6, 11, 16, 18) Gardasil (active) | 2164 |
| J07BM02 | papillomavirus (human types 16, 18) Cervarix (active) | 31 |
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) Gardasil 9 (active) | 0 |
|
|
| J07BX | Other viral vaccines Imvanex (active) | 31 |
| |
|
|
|
|
| J07C | Bacterial and viral vaccines, combined | 59 |
| |
| J07CA | Bacterial and viral vaccines, combined | 59 |
| |
| J07CA01 | natamycin Triacelluvax (withdrawn) | 4 |
| J07CA05 | diphtheria | 0 |
| J07CA07 | diphtheria | 0 |
| J07CA08 | hemophilus influenzae B and hepatitis B Procomvax (not renewed) | 0 |
| J07CA09 | diphtheria | 0 |
| J07CA10 | typhoid | 55 |
| J07CA12 | diphtheria | 0 |
|
|
|
|
|
|
|
|
| L | Antineoplastic and immunomodulating agents | 10533 |
| |
| L01 | Antineoplastic agents | 4438 |
| |
| L01A | Alkylating agents | 98 |
| |
| L01AA | Nitrogen mustard analogues | 88 |
| |
| L01AA05 | clioquinol Ledaga (active) | 0 |
|
|
| L01AB | Alkyl sulphonates | 0 |
| |
| L01AB01 | busulfan Busilvex (active) | 0 |
|
|
| L01AC | Ethylene imines | 0 |
| |
| L01AC01 | thiotepa Tepadina (active) | 0 |
|
|
| L01AD | Nitrosoureas | 5 |
| |
| L01AD01 | carmustine Carmustine Obvius (active) | 4 |
|
|
| L01AX | Other alkylating agents | 5 |
| |
| L01AX03 | temozolomide Temodal (active) | 5 |
| L01AX04 | dacarbazine Dacarbazine Faulding (active) | 0 |
|
|
|
|
| L01B | Antimetabolites | 3181 |
| |
| L01BA | Folic acid analogues | 2215 |
| |
| L01BA01 | methotrexate Jylamvo (active) | 2191 |
| L01BA04 | anagrelide Alimta (active) | 0 |
| L01BA05 | pralatrexate Folotyn (refused) | 0 |
|
|
| L01BB | Purine analogues | 87 |
| |
| L01BB02 | mercaptopurine Mercaptopurine (active) | 84 |
| L01BB04 | cladribine Litak (active) | 0 |
| L01BB06 | clofarabine Evoltra (active) | 0 |
| L01BB07 | nelarabine Atriance (active) | 0 |
|
|
| L01BC | Pyrimidine analogues | 879 |
| |
| L01BC01 | cytarabine DepoCyte (active) | 0 |
| L01BC05 | gemcitabine Gemzar (active) | 1 |
| L01BC06 | capecitabine Capecitabine Accord (active) | 19 |
| L01BC07 | azacitidine Vidaza (active) | 0 |
| L01BC08 | decitabine Dacogen (active) | 0 |
| L01BC53 | tegafur, combinations Teysuno (active) | 0 |
| L01BC59 | trifluridine, combinations Lonsurf (active) | 0 |
|
|
|
|
| L01C | Plant alkaloids and other natural products | 58 |
| |
| L01CA | Vinca alkaloids and analogues | 23 |
| |
| L01CA05 | vinflunine Javlor (active) | 0 |
| L01CA06 | vintafolide Vynfinit (refused) | 0 |
|
|
| L01CB | Podophyllotoxin derivatives | 0 |
| |
| L01CB01 | etoposide Etopophos and associated names (active) | 0 |
|
|
| L01CD | Taxanes | 35 |
| |
| L01CD01 | parecoxib Abraxane (active) | 35 |
| L01CD02 | docetaxel Docefrez (withdrawn) | 0 |
| L01CD04 | cabazitaxel JEVTANA (active) | 0 |
|
|
| L01CX | Other plant alkaloids and natural products | 0 |
| |
| L01CX01 | trabectedin Yondelis (refused) | 0 |
|
|
|
|
| L01D | Cytotoxic antibiotics | 146 |
| |
| L01DB | Anthracyclines | 126 |
| |
| L01DB01 | doxorubicin Caelyx (active) | 126 |
| L01DB11 | pixantrone Pixuvri (active) | 0 |
|
|
|
|
| L01X | Other antineoplastic agents | 955 |
| |
| L01XC | Monoclonal antibodies | 14 |
| |
| L01XC02 | rituximab Blitzima (active) | 8 |
| L01XC03 | milnacipran Herceptin (active) | 5 |
| L01XC04 | alemtuzumab MabCampath (withdrawn) | 0 |
| L01XC05 | gemtuzumab Mylotarg (active) | 0 |
| L01XC06 | cetuximab Erbitux (active) | 0 |
| L01XC07 | bevacizumab Avastin (active) | 0 |
| L01XC08 | panitumumab Vectibix (active) | 0 |
| L01XC09 | catumaxomab Removab (withdrawn) | 0 |
| L01XC10 | ofatumumab Arzerra (active) | 0 |
| L01XC11 | ipilimumab Yervoy (active) | 0 |
| L01XC12 | brentuximab vedotin ADCETRIS (active) | 0 |
| L01XC13 | pertuzumab Perjeta (active) | 0 |
| L01XC14 | trastuzumab emtansine Kadcyla (active) | 0 |
| L01XC15 | trametinib Gazyvaro (active) | 0 |
| L01XC16 | dinutuximab Unituxin (withdrawn) | 0 |
| L01XC17 | fluciclovine (18F) Nivolumab BMS (withdrawn) | 0 |
| L01XC18 | pembrolizumab KEYTRUDA (active) | 0 |
| L01XC19 | blinatumomab Blincyto (active) | 0 |
| L01XC21 | ramucirumab Cyramza (active) | 0 |
| L01XC22 | moxidectin Portrazza (active) | 0 |
| L01XC23 | elotuzumab Empliciti (active) | 0 |
| L01XC24 | cariprazine Darzalex (active) | 0 |
| L01XC26 | inotuzumab ozogamicin Besponsa (active) | 0 |
| L01XC27 | olaratumab Lartruvo (active) | 0 |
| L01XC31 | avelumab Bavencio (active) | 0 |
| L01XC32 | atezolizumab Tecentriq (active) | 0 |
|
|
| L01XD | Sensitizers used in photodynamic/radiation therapy | 0 |
| |
| L01XD01 | porfimer sodium PhotoBarr (withdrawn) | 0 |
| L01XD04 | aminolevulinic acid Ameluz (active) | 0 |
| L01XD05 | temoporfin Foscan (active) | 0 |
| L01XD07 | padeliporfin TOOKAD (active) | 0 |
|
|
| L01XE | Protein kinase inhibitors | 33 |
| |
| L01XE01 | pivagabine Glivec (active) | 19 |
| L01XE02 | budesonide Iressa (active) | 0 |
| L01XE03 | beclometasone Tarceva (active) | 1 |
| L01XE04 | sunitinib Sutent (active) | 8 |
| L01XE05 | sorafenib Nexavar (active) | 0 |
| L01XE06 | dasatinib Sprycel (active) | 4 |
| L01XE07 | lapatinib Tyverb (active) | 0 |
| L01XE08 | nilotinib Tasigna (active) | 0 |
| L01XE09 | temsirolimus Torisel (active) | 0 |
| L01XE10 | everolimus Afinitor (active) | 0 |
| L01XE11 | pazopanib Votrient (active) | 1 |
| L01XE12 | vandetanib Caprelsa (active) | 0 |
| L01XE13 | afatinib Giotrif (active) | 0 |
| L01XE14 | bosutinib Bosulif (active) | 0 |
| L01XE15 | vemurafenib Zelboraf (active) | 0 |
| L01XE16 | crizotinib XALKORI (active) | 0 |
| L01XE17 | axitinib Inlyta (active) | 0 |
| L01XE18 | ruxolitinib Jakavi (active) | 0 |
| L01XE21 | regorafenib Stivarga (active) | 0 |
| L01XE22 | masitinib Alsitek (refused) | 0 |
| L01XE23 | dabrafenib Tafinlar (active) | 0 |
| L01XE24 | ponatinib Iclusig (active) | 0 |
| L01XE25 | trametinib Mekinist (active) | 0 |
| L01XE26 | dihydrostreptomycin CABOMETYX (active) | 0 |
| L01XE27 | ibrutinib IMBRUVICA (active) | 0 |
| L01XE28 | ceritinib Zykadia (active) | 0 |
| L01XE29 | rolapitant Kisplyx (active) | 0 |
| L01XE31 | nintedanib Ofev (active) | 0 |
| L01XE33 | palbociclib IBRANCE (active) | 0 |
| L01XE34 | tivozanib Fotivda (active) | 0 |
| L01XE35 | osimertinib TAGRISSO (active) | 0 |
| L01XE36 | alectinib Alecensa (active) | 0 |
| L01XE38 | cobimetinib Cotellic (active) | 0 |
| L01XE39 | midostaurin Rydapt (active) | 0 |
| L01XE42 | ribociclib Kisqali (active) | 0 |
|
|
| L01XX | Other antineoplastic agents | 863 |
| |
| L01XX02 | asparaginase Spectrila (active) | 0 |
| L01XX05 | hydroxycarbamide Siklos (active) | 290 |
| L01XX17 | topotecan Evotopin (withdrawn) | 0 |
| L01XX19 | irinotecan Onivyde (active) | 0 |
| L01XX22 | reboxetine Panretin (active) | 0 |
| L01XX23 | mitotane Lysodren (active) | 0 |
| L01XX24 | pegaspargase Oncaspar (active) | 0 |
| L01XX25 | bexarotene Targretin (active) | 0 |
| L01XX27 | desvenlafaxine Trisenox (active) | 0 |
| L01XX32 | bortezomib Bortezomib Accord (active) | 0 |
| L01XX33 | celecoxib Onsenal (withdrawn) | 0 |
| L01XX35 | anagrelide Anagrelide (active) | 12 |
| L01XX39 | romidepsin Istodax (refused) | 0 |
| L01XX41 | eribulin HALAVEN (active) | 0 |
| L01XX42 | panobinostat Farydak (active) | 0 |
| L01XX43 | vismodegib Erivedge (active) | 0 |
| L01XX44 | aflibercept ZALTRAP (active) | 0 |
| L01XX45 | carfilzomib Kyprolis (active) | 0 |
| L01XX46 | olaparib Lynparza (active) | 0 |
| L01XX47 | idelalisib Zydelig (active) | 0 |
| L01XX48 | sonidegib Odomzo (active) | 0 |
| L01XX50 | ixazomib Ninlaro (active) | 0 |
| L01XX51 | talimogene laherparepvec Imlygic (active) | 0 |
| L01XX52 | venetoclax Venclyxto (active) | 0 |
| L01XX54 | niraparib Zejula (active) | 0 |
| L01XX55 | rucaparib Rubraca (active) | 0 |
| L01XX56 | etirinotecan pegol Onzeald (refused) | 0 |
| L01XX57 | plitidepsin Aplidin (refused) | 0 |
|
|
|
|
|
|
| L02 | Endocrine therapy | 3970 |
| |
| L02A | Hormones and related agents | 1168 |
| |
| L02AE | Gonadotrophin releasing hormone analogues | 163 |
| |
| L02AE03 | goserelin Goserelin cell pharm 3,6 mg Implantat and associated names (active) | 92 |
|
|
|
|
| L02B | Hormone antagonists and related agents | 2802 |
| |
| L02BA | Anti | 756 |
| |
| L02BA02 | toremifene Fareston (active) | 0 |
| L02BA03 | fulvestrant Faslodex (active) | 0 |
|
|
| L02BB | Anti | 293 |
| |
| L02BB03 | bicalutamide Bicaluplex (active) | 229 |
| L02BB04 | enzalutamide Xtandi (active) | 0 |
|
|
| L02BG | Enzyme inhibitors | 1746 |
| |
| L02BG03 | anastrozole Arimidex (active) | 551 |
| L02BG04 | letrozole Femara and associated names (active) | 1111 |
|
|
| L02BX | Other hormone antagonists and related agents | 7 |
| |
| L02BX02 | degarelix Firmagon (active) | 0 |
| L02BX03 | abiraterone Zytiga (active) | 7 |
|
|
|
|
|
|
| L03 | Immunomodulating agents | 113 |
| |
| L03A | Immunostimulating agents | 113 |
| |
| L03AA | Cytokines | 6 |
| |
| L03AA02 | filgrastim Accofil (active) | 6 |
| L03AA03 | molgramostim Leucomax/Mielogen/SCH34300 (active) | 0 |
| L03AA13 | pegfilgrastim Neulasta (active) | 0 |
| L03AA14 | lipegfilgrastim Lonquex (active) | 0 |
| L03AA15 | balugrastim Egranli (withdrawn) | 0 |
|
|
| L03AB | Interferons | 78 |
| |
| L03AB01 | levacetylmethadol Roferon | 0 |
| L03AB05 | interferon gamma Intron A (active) | 0 |
| L03AB07 | interferon alfa | 25 |
| L03AB08 | interferon alfa | 12 |
| L03AB09 | interferon beta | 0 |
| L03AB10 | peginterferon alfa | 16 |
| L03AB11 | peginterferon alfa | 0 |
| L03AB13 | peginterferon beta | 0 |
|
|
| L03AX | Other immunostimulating agents | 29 |
| |
| L03AX11 | tasonermin Beromun (active) | 0 |
| L03AX14 | histamine dihydrochloride Ceplene (active) | 0 |
| L03AX15 | mifamurtide Mepact (active) | 0 |
| L03AX16 | plerixafor Mozobil (active) | 0 |
| L03AX17 | sipuleucel | 0 |
| L03AX19 | dasiprotimut | 0 |
|
|
|
|
|
|
| L04 | Immunosuppressive agents | 2012 |
| |
| L04A | Immunosuppressive agents | 2012 |
| |
| L04AA | Selective immunosuppressive agents | 489 |
| |
| L04AA02 | muromonab | 0 |
| L04AA06 | mycophenolic acid CellCept (active) | 236 |
| L04AA10 | sirolimus Rapamune (active) | 27 |
| L04AA13 | leflunomide Arava (active) | 221 |
| L04AA21 | efalizumab Raptiva (withdrawn) | 0 |
| L04AA23 | natalizumab Natalizumab Elan Pharma (refused) | 0 |
| L04AA24 | abatacept Orencia (active) | 4 |
| L04AA25 | eculizumab Soliris (active) | 0 |
| L04AA26 | ofatumumab Benlysta (active) | 0 |
| L04AA27 | fingolimod GILENYA (active) | 1 |
| L04AA28 | eltrombopag NULOJIX (active) | 0 |
| L04AA29 | tofacitinib Xeljanz (refused) | 0 |
| L04AA31 | teriflunomide AUBAGIO (active) | 0 |
| L04AA32 | apremilast Otezla (active) | 0 |
| L04AA33 | vedolizumab Entyvio (active) | 0 |
| L04AA34 | alemtuzumab Lemtrada (active) | 0 |
| L04AA36 | selective immunosuppressants Ocrevus (active) | 0 |
| L04AA37 | baricitinib Olumiant (active) | 0 |
| L04AA40 | cladribine MAVENCLAD (active) | 0 |
|
|
| L04AB | Tumor necrosis factor alpha (TNF | 330 |
| |
| L04AB01 | etanercept Benepali (active) | 137 |
| L04AB02 | infliximab Flixabi (active) | 46 |
| L04AB04 | adalimumab AMGEVITA (active) | 131 |
| L04AB05 | certolizumab pegol Cimzia (active) | 1 |
| L04AB06 | golimumab Simponi (active) | 15 |
|
|
| L04AC | Interleukin inhibitors | 22 |
| |
| L04AC01 | valdecoxib Zenapax (withdrawn) | 0 |
| L04AC03 | anakinra Kineret (active) | 1 |
| L04AC04 | rilonacept Rilonacept Regeneron (withdrawn) | 0 |
| L04AC05 | ustekinumab Stelara (active) | 6 |
| L04AC07 | tocilizumab RoActemra (active) | 15 |
| L04AC08 | canakinumab Ilaris (active) | 0 |
| L04AC10 | secukinumab Cosentyx (active) | 0 |
| L04AC11 | lopinavir and ritonavir Sylvant (active) | 0 |
| L04AC12 | brodalumab Kyntheum (active) | 0 |
| L04AC13 | ixekizumab Taltz (active) | 0 |
| L04AC14 | sarilumab Kevzara (active) | 0 |
|
|
| L04AD | Calcineurin inhibitors | 179 |
| |
| L04AD02 | tacrolimus Advagraf (active) | 58 |
| L04AD03 | voclosporin Luveniq (refused) | 0 |
|
|
| L04AX | Other immunosuppressive agents | 992 |
| |
| L04AX02 | thalidomide Thalidomide Celgene (active) | 0 |
| L04AX03 | methotrexate Nordimet (active) | 0 |
| L04AX04 | lenalidomide Revlimid (active) | 2 |
| L04AX05 | pirfenidone Esbriet (active) | 4 |
| L04AX06 | pomalidomide Imnovid (active) | 0 |
|
|
|
|
|
|
|
|
| M | Musculo-Skeletal System | 206813 |
| |
| M01 | Antiinflammatory and antirheumatic products | 142204 |
| |
| M01A | Antiinflammatory and antirheumatic products, non | 142020 |
| |
| M01AC | Oxicams | 2371 |
| |
| M01AC01 | piroxicam Piroxicam (active) | 384 |
| M01AC05 | lornoxicam Xefo (active) | 0 |
|
|
| M01AE | Propionic acid derivatives | 52244 |
| |
| M01AE03 | ketoprofen Ketoprofen (active) | 363 |
|
|
| M01AH | Coxibs | 29831 |
| |
| M01AH02 | rofecoxib Rofecoxib (active) | 6675 |
| M01AH03 | valdecoxib Bextra (not renewed) | 718 |
| M01AH04 | parecoxib Dynastat (active) | 0 |
| M01AH05 | etoricoxib Arcoxia and associated names (active) | 0 |
| M01AH06 | lumiracoxib Lumiracoxib (active) | 55 |
|
|
| M01AX | Other antiinflammatory and antirheumatic agents, non | 18 |
| |
| M01AX05 | glucosamine Glucomed (active) | 0 |
| M01AX17 | nimesulide Coxtral Gel (active) | 0 |
| M01AX21 | diacerein Diacerein (active) | 0 |
|
|
|
|
|
|
| M03 | Muscle relaxants | 21121 |
| |
| M03A | Muscle relaxants, peripherally acting agents | 104 |
| |
| M03AX | Other muscle relaxants, peripherally acting | 96 |
| |
| M03AX01 | botulinum toxin NeuroBloc (active) | 96 |
|
|
|
|
| M03B | Muscle relaxants, centrally acting agents | 20961 |
| |
| M03BA | Carbamic acid esters | 632 |
| |
| M03BA02 | carisoprodol Carisoprodol (active) | 4 |
|
|
| M03BB | Oxazol | 412 |
| |
| M03BB02 | chlormezanone Chlormezanone (active) | 0 |
|
|
| M03BX | Other centrally acting agents | 19587 |
| |
| M03BX04 | tolperisone Merisone and associated names (active) | 0 |
| M03BX05 | thiocolchicoside Thiocolchicoside (active) | 0 |
| M03BX07 | tetrazepam Tetrazepam (suspended) | 0 |
|
|
|
|
|
|
| M04 | Antigout preparations | 19398 |
| |
| M04A | Antigout preparations | 19398 |
| |
| M04AA | Preparations inhibiting uric acid production | 16049 |
| |
| M04AA03 | febuxostat Adenuric (active) | 78 |
|
|
| M04AB | Preparations increasing uric acid excretion | 519 |
| |
| M04AB05 | lesinurad Zurampic (active) | 0 |
|
|
| M04AX | Other antigout preparations | 0 |
| |
| M04AX02 | pegloticase Krystexxa (withdrawn) | 0 |
|
|
|
|
|
|
| M05 | Drugs for treatment of bone diseases | 18078 |
| |
| M05B | Drugs affecting bone structure and mineralization | 18078 |
| |
| M05BA | Biphosphonates | 16934 |
| |
| M05BA04 | alendronic acid Alendronate Hexal (active) | 13995 |
| M05BA06 | ibandronic acid Bondenza (withdrawn) | 0 |
| M05BA08 | zoledronic acid Aclasta (active) | 26 |
|
|
| M05BB | Bisphosphonates, combinations | 732 |
| |
| M05BB03 | alendronic acid and colecalciferol Adrovance (active) | 86 |
| M05BB04 | risedronic acid, calcium and colecalciferol, sequential Fortipan Combi D and associated names (active) | 0 |
|
|
| M05BC | Bone morphogenetic proteins | 0 |
| |
| M05BC01 | dibotermin alfa InductOs (active) | 0 |
| M05BC02 | eptotermin alfa Opgenra (withdrawn) | 0 |
|
|
| M05BX | Other drugs affecting bone structure and mineralization | 412 |
| |
| M05BX03 | flupirtine Osseor (active) | 0 |
| M05BX04 | denosumab Prolia (active) | 412 |
|
|
|
|
|
|
| M09 | Other drugs for disorders of the musculo-skeletal system | 0 |
| |
| M09A | Other drugs for disorders of the musculo-skeletal system | 0 |
| |
| M09AB | Enzymes | 0 |
| |
| M09AB02 | collagenase clostridium histolyticum Xiapex (active) | 0 |
|
|
| M09AX | Other drugs for disorders of the musculo | 0 |
| |
| M09AX02 | chondrocytes, autologous ChondroCelect (withdrawn) | 0 |
| M09AX03 | ataluren Translarna (active) | 0 |
| M09AX07 | nusinersen Spinraza (active) | 0 |
|
|
|
|
|
|
|
|
| N | Nervous system | 897145 |
| |
| N01 | Anesthetics | 2868 |
| |
| N01A | Anesthetics, general | 843 |
| |
| N01AH | Opioid anesthetics | 241 |
| |
| N01AH01 | fentanyl Fentanyl (Fentador) (active) | 35 |
| N01AH03 | sufentanil Dzuveo (active) | 2 |
|
|
|
|
| N01B | Anesthetics, local | 2025 |
| |
| N01BB | Amides | 713 |
| |
| N01BB20 | combinations Fortacin (active) | 1 |
| N01BB52 | lidocaine, combinations Caustinerf arsenical, Yranicid arsenical and other associated names for topical use (active) | 128 |
|
|
| N01BX | Other local anesthetics | 14 |
| |
| N01BX04 | capsaicin Qutenza (active) | 5 |
|
|
|
|
|
|
| N02 | Analgesics | 224587 |
| |
| N02A | Opioids | 142516 |
| |
| N02AB | Phenylpiperidine derivatives | 6657 |
| |
| N02AB03 | fentanyl Effentora (active) | 4796 |
|
|
| N02AC | Diphenylpropylamine derivatives | 22 |
| |
| N02AC54 | dextropropoxyphene, combinations excluding psycholept Dextropropoxyphene (active) | 0 |
|
|
| N02AX | Other opioids | 12913 |
| |
| N02AX02 | etenzamide, combinations with psycholeptics Tramadol hydrochloride (refused) | 2023 |
|
|
|
|
| N02B | Other analgesics and antipyretics | 60485 |
| |
| N02BG | Other analgesics and antipyretics | 10 |
| |
| N02BG07 | flupirtine Flupirtine (active) | 0 |
| N02BG08 | entacapone Prialt (active) | 0 |
|
|
|
|
| N02C | Antimigraine preparations | 21586 |
| |
| N02CX | Other antimigraine preparations | 1693 |
| |
| N02CX04 | sumatriptan Sumatriptan Galpharm (refused) | 0 |
|
|
|
|
|
|
| N03 | Antiepileptics | 95249 |
| |
| N03A | Antiepileptics | 95249 |
| |
| N03AF | Carboxamide derivatives | 5724 |
| |
| N03AF03 | treprostinil Inovelon (active) | 0 |
| N03AF04 | eslicarbazepine Exalief (expired / sunset clause) | 0 |
|
|
| N03AG | Fatty acid derivatives | 5109 |
| |
| N03AG01 | valproic acid Valproate | 5094 |
| N03AG04 | vigabatrin Vigabatrin (active) | 15 |
|
|
| N03AX | Other antiepileptics | 44421 |
| |
| N03AX09 | lamotrigine Lamictal and associated names (active) | 3410 |
| N03AX11 | topiramate Topamax (active) | 4037 |
| N03AX12 | gabapentin Neurontin (active) | 31875 |
| N03AX14 | levetiracetam Keppra (active) | 930 |
| N03AX15 | zonisamide Zonegran (active) | 0 |
| N03AX16 | pregabalin Lyrica (active) | 4134 |
| N03AX17 | stiripentol Diacomit (active) | 0 |
| N03AX18 | lacosamide Lacosamide Accord (active) | 34 |
| N03AX21 | retigabine Trobalt (active) | 0 |
| N03AX22 | perampanel Fycompa (active) | 1 |
| N03AX23 | brivaracetam Briviact (active) | 0 |
|
|
|
|
|
|
| N04 | Anti | 11572 |
| |
| N04B | Dopaminergic agents | 10240 |
| |
| N04BA | Dopa and dopa derivatives | 5494 |
| |
| N04BA02 | levodopa and decarboxylase inhibitor Numient (active) | 5494 |
| N04BA03 | levodopa, decarboxylase inhibitor and comt inhibitor Corbilta (active) | 0 |
|
|
| N04BC | Dopamine agonists | 4375 |
| |
| N04BC04 | ropinirole Adartrel (active) | 1074 |
| N04BC05 | pramipexole Daquiran (withdrawn) | 3223 |
| N04BC09 | rotigotine Leganto (active) | 0 |
|
|
| N04BD | Monoamine oxidase type B inhibitors | 96 |
| |
| N04BD02 | rasagiline Azilect (active) | 17 |
| N04BD03 | safinamide Xadago (active) | 0 |
|
|
| N04BX | Other dopaminergic agents | 78 |
| |
| N04BX01 | tolcapone Tasmar (active) | 0 |
| N04BX02 | entacapone Comtan (active) | 78 |
| N04BX04 | opicapone Ongentys (active) | 0 |
|
|
|
|
|
|
| N05 | Psycholeptics | 216900 |
| |
| N05A | Antipsychotics | 41778 |
| |
| N05AD | Butyrophenone derivatives | 639 |
| |
| N05AD01 | haloperidol Haldol and associated names (active) | 639 |
|
|
| N05AE | Indole derivatives | 172 |
| |
| N05AE03 | sertindole Sertindole (active) | 0 |
| N05AE05 | lurasidone Latuda (active) | 32 |
|
|
| N05AH | Diazepines, oxazepines, thiazepines and oxepines | 21160 |
| |
| N05AH01 | loxapine Adasuve (active) | 122 |
| N05AH02 | clozapine Clozapine (Leponex) (active) | 426 |
| N05AH03 | olanzapine Olansek (withdrawn) | 4909 |
| N05AH04 | quetiapine Seroquel XR and associated names (active) | 15692 |
| N05AH05 | asenapine Sycrest (active) | 11 |
|
|
| N05AL | Benzamides | 0 |
| |
| N05AL06 | veralipride Agreal (withdrawn) | 0 |
|
|
| N05AX | Other antipsychotics | 12099 |
| |
| N05AX08 | risperidone Risperdal (active) | 9847 |
| N05AX12 | aripiprazole Abilify (active) | 2213 |
| N05AX13 | paliperidone Invega (active) | 39 |
| N05AX14 | iloperidone Fanaptum (refused) | 0 |
| N05AX15 | cariprazine Reagila (active) | 0 |
|
|
|
|
| N05C | Hypnotics and sedatives | 87033 |
| |
| N05CD | Benzodiazepine derivatives | 15599 |
| |
| N05CD08 | midazolam Buccolam (active) | 4 |
|
|
| N05CF | Cyclopyrrolones | 70266 |
| |
| N05CF03 | zaleplon Sonata (withdrawn) | 271 |
| N05CF04 | eszopiclone Lunivia (withdrawn) | 0 |
|
|
| N05CH | Melatonin receptor agonists | 0 |
| |
| N05CH01 | melatonin Circadin (active) | 0 |
| N05CH03 | tasimelteon Hetlioz (active) | 0 |
|
|
| N05CM | Other hypnotics and sedatives | 162 |
| |
| N05CM18 | dexmedetomidine Dexdor (active) | 0 |
|
|
|
|
|
|
| N06 | Psychoanaleptics | 322249 |
| |
| N06A | Antidepressants | 295850 |
| |
| N06AB | Bicyclic derivatives | 128655 |
| |
| N06AB03 | fluoxetine Fluoxetin NM (active) | 15213 |
| N06AB04 | citalopram SSRIs, SNRIs (active) | 56016 |
| N06AB05 | paroxetine Paroxetine (active) | 21336 |
| N06AB06 | sertraline SSRIs, SNRIs (active) | 23545 |
| N06AB08 | fluvoxamine Fluvoxamine (active) | 2779 |
| N06AB10 | escitalopram Escitalopram (active) | 9766 |
|
|
| N06AX | Other antidepressants | 113591 |
| |
| N06AX11 | mirtazapine Remeron (active) | 10626 |
| N06AX12 | bupropion Bupropion (active) | 23144 |
| N06AX16 | venlafaxine Efexor (active) | 54709 |
| N06AX17 | milnacipran Impulsor (refused) | 0 |
| N06AX18 | reboxetine SSRIs, SNRIs (active) | 0 |
| N06AX21 | duloxetine Ariclaim (active) | 6572 |
| N06AX22 | agomelatine Thymanax (refused) | 0 |
| N06AX26 | vortioxetine Brintellix (active) | 0 |
|
|
|
|
| N06B | Psychostimulants | 22521 |
| |
| N06BA | Phenylethylamine derivatives | 22376 |
| |
| N06BA04 | methylphenidate methylphenidate (active) | 16910 |
| N06BA07 | modafinil Modafinil containing medicinal products (active) | 388 |
| N06BA09 | atomoxetine SSRIs, SNRIs (active) | 967 |
|
|
| N06BC | Xanthine derivatives | 144 |
| |
| N06BC01 | caffeine Peyona (active) | 144 |
| N06BC02 | propentofylline Kronos (refused) | 0 |
|
|
| N06BX | Other psychostimulants | 1 |
| |
| N06BX13 | idebenone Raxone (active) | 0 |
|
|
|
|
| N06D | Anti | 3637 |
| |
| N06DA | Anticholinesterases | 3510 |
| |
| N06DA03 | rivastigmine Exelon (active) | 189 |
| N06DA04 | galantamine Galantamine STADA and associated names (active) | 543 |
| N06DA52 | donepezil and memantine Balaxur (refused) | 0 |
|
|
| N06DX | Other anti | 127 |
| |
| N06DX01 | memantine Axura (active) | 127 |
|
|
|
|
|
|
| N07 | Other nervous system drugs | 23720 |
| |
| N07B | Drugs used in addictive disorders | 13448 |
| |
| N07BA | Drugs used in nicotine dependence | 13173 |
| |
| N07BA03 | varenicline Champix (active) | 11537 |
|
|
| N07BB | Drugs used in alcohol dependence | 165 |
| |
| N07BB05 | nalmefene Selincro (active) | 0 |
|
|
| N07BC | Drugs used in opioid dependence | 110 |
| |
| N07BC03 | efavirenz Orlaam (withdrawn) | 0 |
| N07BC51 | methadone Suboxone (active) | 69 |
|
|
|
|
| N07C | Antivertigo preparations | 9703 |
| |
| N07CA | Antivertigo preparations | 9703 |
| |
| N07CA01 | betahistine Betavert N and associated names (active) | 9459 |
|
|
|
|
| N07X | Other nervous system drugs | 25 |
| |
| N07XX | Other nervous system drugs | 25 |
| |
| N07XX02 | riluzole Rilutek (active) | 4 |
| N07XX04 | hydroxybutyric acid Xyrem (active) | 0 |
| N07XX05 | amifampridine Firdapse (active) | 0 |
| N07XX07 | fampridine Fampyra (active) | 3 |
| N07XX08 | tafamidis Vyndaqel (active) | 0 |
| N07XX09 | dimethyl fumarate Tecfidera (active) | 5 |
| N07XX11 | pitolisant Wakix (active) | 0 |
| N07XX59 | dextromethorphan, combinations Nuedexta (withdrawn) | 0 |
|
|
|
|
|
|
|
|
| P | Antiparasitic products | 12119 |
| |
| P01 | Antiprotozoals | 8745 |
| |
| P01B | Antimalarials | 6422 |
| |
| P01BF | Artemisinin and derivatives, combinations | 0 |
| |
| P01BF05 | artenimol and piperaquine Eurartesim (active) | 0 |
|
|
|
|
|
|
|
|
| R | Respiratory system | 292789 |
| |
| R01 | Nasal preparations | 77637 |
| |
| R01A | Nasal decongestants for topical use | 76141 |
| |
| R01AD | Corticosteroids | 70066 |
| |
| R01AD09 | mometasone Mometasone Furoate Sandoz and associated names (active) | 39988 |
| R01AD12 | flucticasone furoate Alisade (expired / sunset clause) | 8241 |
|
|
|
|
|
|
| R03 | Anti | 178663 |
| |
| R03A | Adrenergics, inhalants | 119160 |
| |
| R03AC | Selective beta | 83270 |
| |
| R03AC02 | salbutamol Sabumalin and associated names (active) | 78685 |
| R03AC13 | formoterol Atifor Chiesi 12 mcg (active) | 1149 |
| R03AC18 | indacaterol Hirobriz Breezhaler (active) | 67 |
|
|
| R03AK | Adrenergics and other anti | 35580 |
| |
| R03AK06 | salmeterol and other drugs for obstructive airway diseases Aerivio Spiromax (active) | 19790 |
| R03AK07 | formoterol and budesonide BiResp Spiromax (active) | 13315 |
| R03AK10 | vilanterol and fluticasone furoate Relvar Ellipta (active) | 483 |
|
|
| R03AL | Adrenergics in combination with anticholinergics | 246 |
| |
| R03AL03 | vilanterol and umeclidinium bromide Anoro (active) | 117 |
| R03AL04 | indacaterol and glycopyrronium bromide Ultibro Breezhaler (active) | 27 |
| R03AL05 | metformin and dapagliflozin Brimica Genuair (active) | 0 |
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate Elebrato Ellipta (active) | 0 |
| R03AL09 | formoterol, glycopyrronium bromide and beclometasone Trimbow (active) | 0 |
|
|
|
|
| R03B | Other anti | 43988 |
| |
| R03BA | Glucocorticoids | 30063 |
| |
| R03BA01 | beclometasone Clenil and associated names (active) | 3136 |
| R03BA02 | budesonide Pulairmax (active) | 3457 |
| R03BA08 | ciclesonide Alvesco (active) | 3299 |
|
|
| R03BB | Anticholinergics | 13796 |
| |
| R03BB05 | aflibercept Bretaris Genuair (active) | 99 |
| R03BB06 | glycopyrronium bromide Enurev Breezhaler (active) | 80 |
| R03BB07 | umeclidinium bromide Incruse (active) | 0 |
|
|
|
|
| R03C | Adrenergics for systemic use | 1344 |
| |
|
|
| R03D | Other anti | 14171 |
| |
| R03DC | Leukotriene receptor antagonists | 13355 |
| |
| R03DC03 | montelukast Singulair (active) | 13095 |
|
|
| R03DX | Other anti | 109 |
| |
| R03DX05 | omalizumab Xolair (active) | 6 |
| R03DX07 | roflumilast Daliresp (withdrawn) | 103 |
| R03DX08 | avelumab Cinqaero (active) | 0 |
| R03DX09 | mepolizumab Nucala (active) | 0 |
| R03DX10 | benralizumab Fasenra (active) | 0 |
|
|
|
|
|
|
| R05 | Cough and cold preparations | 15265 |
| |
| R05C | Expectorants, excluding combinations with antitussives | 905 |
| |
| R05CB | Mucolytics | 13 |
| |
| R05CB16 | mannitol Bronchitol (active) | 0 |
|
|
|
|
| R05D | Antitussives, excluding combinations with expectorants | 7288 |
| |
| R05DA | Opium alkaloids and derivatives | 7288 |
| |
| R05DA08 | pholcodine Pholcodine containing medicinal products (active) | 0 |
|
|
| R05DB | Antitussives chemically close to local anesthetics | 0 |
| |
| R05DB03 | clobutinol Clobutinol (active) | 0 |
|
|
|
|
|
|
| R06 | Antihistamines for systemic use | 20978 |
| |
| R06A | Antihistamines for systemic use | 20978 |
| |
| R06AE | Piperazine derivatives | 5212 |
| |
| R06AE07 | cetirizine Zyrtec (active) | 4853 |
|
|
| R06AX | Other antihistamines for systemic use | 3078 |
| |
| R06AX12 | terfenadine Terfenadine (active) | 1 |
| R06AX13 | loratadine Loratadine (active) | 1182 |
| R06AX25 | mizolastine Mizollen (active) | 0 |
| R06AX27 | desloratadine Aerinaze (active) | 1559 |
|
|
|
|
|
|
| R07 | Other respiratory system products | 32 |
| |
| R07A | Other respiratory system products | 32 |
| |
| R07AX | Other respiratory system products | 21 |
| |
| R07AX01 | nitric oxide INOmax (active) | 15 |
| R07AX02 | ivacaftor Kalydeco (active) | 0 |
| R07AX30 | ivacaftor and lumacaftor Orkambi (active) | 0 |
|
|
|
|
|
|
|
|
| S | Sensory organs | 54822 |
| |
| S01 | Ophthalmologicals | 36300 |
| |
| S01A | Antiinfectives | 19063 |
| |
| S01AD | Antivirals | 51 |
| |
| S01AD08 | fomivirsen Vitravene (withdrawn) | 0 |
|
|
| S01AX | Other antiinfectives | 4132 |
| |
| S01AX12 | norfloxacin Norfloxacin (active) | 1 |
|
|
|
|
| S01B | Antiinflammatory agents | 3027 |
| |
| S01BA | Corticosteroids, plain | 1130 |
| |
| S01BA01 | dexamethasone Ozurdex (active) | 357 |
|
|
| S01BC | Antiinflammatory agents, non | 1897 |
| |
| S01BC10 | nepafenac Nevanac (active) | 20 |
| S01BC11 | bromfenac Yellox (active) | 0 |
|
|
|
|
| S01E | Antiglaucoma preparations and miotics | 4054 |
| |
| S01EC | Carbonic anhydrase inhibitors | 695 |
| |
| S01EC04 | brinzolamide Azopt (active) | 250 |
| S01EC54 | brinzolamide, combinations Simbrinza (active) | 0 |
|
|
| S01ED | Beta blocking agents | 1240 |
| |
| S01ED51 | timolol, combinations Azarga (active) | 417 |
|
|
| S01EE | Prostaglandin analogues | 1646 |
| |
| S01EE01 | latanoprost Xalatan (active) | 667 |
| S01EE03 | bimatoprost Lumigan (active) | 516 |
| S01EE04 | travoprost Izba (active) | 463 |
|
|
|
|
| S01F | Mydriatics and cycloplegics | 130 |
| |
| S01FB | Sympathomimetics excluding antiglaucoma preparations | 11 |
| |
| S01FB51 | phenylephrine and ketorolac Omidria (active) | 0 |
|
|
|
|
| S01G | Decongestants and antiallergics | 5723 |
| |
| S01GX | Other antiallergics | 4344 |
| |
| S01GX06 | emedastine Emadine (active) | 7 |
| S01GX09 | olopatadine Opatanol (active) | 3114 |
|
|
|
|
| S01L | Ocular vascular disorder agents | 6 |
| |
| S01LA | Antineovascularisation agents | 6 |
| |
| S01LA01 | verteporfin Visudyne (active) | 0 |
| S01LA03 | pegaptanib Macugen (active) | 0 |
| S01LA04 | ranibizumab Lucentis (active) | 6 |
| S01LA05 | aflibercept Eylea (active) | 0 |
|
|
|
|
| S01X | Other ophthalmologicals | 1430 |
| |
| S01XA | Other ophthalmologicals | 1430 |
| |
| S01XA18 | ciclosporin IKERVIS (active) | 48 |
| S01XA19 | limbal stems cells, autologous Holoclar (active) | 0 |
| S01XA21 | mercaptamine Cystadrops (active) | 0 |
| S01XA22 | ocriplasmin JETREA (active) | 0 |
| S01XA24 | cenegermin OXERVATE (active) | 0 |
|
|
|
|
|
|
|
|
| V | Various | 22153 |
| |
| V03 | All other therapeutic products | 4544 |
| |
| V03A | All other therapeutic products | 4544 |
| |
| V03AB | Antidotes | 68 |
| |
| V03AB15 | naloxone Nyxoid (active) | 46 |
| V03AB17 | methylthionine Methylthioninium chloride Proveblue (active) | 9 |
| V03AB33 | hydroxocobalamin Cyanokit (active) | 0 |
| V03AB35 | sugammadex Bridion (active) | 0 |
| V03AB37 | idarucizumab Praxbind (active) | 0 |
|
|
| V03AC | Iron chelating agents | 8 |
| |
| V03AC02 | deferiprone Ferriprox (active) | 0 |
| V03AC03 | deferasirox Exjade (active) | 1 |
|
|
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia | 344 |
| |
| V03AE02 | sevelamer Renagel (active) | 14 |
| V03AE05 | sucroferric oxyhydroxide Velphoro (active) | 0 |
| V03AE06 | colestilan BindRen (withdrawn) | 0 |
| V03AE09 | patiromer calcium Veltassa (active) | 0 |
| V03AE10 | sodium zirconium cyclosilicate Lokelma (active) | 0 |
|
|
| V03AF | Detoxifying agents for antineoplastic treatment | 251 |
| |
| V03AF02 | dexrazoxane Dexrazoxane (active) | 231 |
| V03AF03 | calcium folinate Lederfoline (active) | 20 |
| V03AF07 | rasburicase Fasturtec (active) | 0 |
| V03AF08 | palifermin Kepivance (withdrawn) | 0 |
|
|
| V03AX | Other therapeutic products | 2 |
| |
| V03AX02 | nalfurafine Winfuran (refused) | 0 |
| V03AX03 | cobicistat Tybost (active) | 0 |
|
|
|
|
|
|
| V04 | Diagnostic agents | 4454 |
| |
| V04C | Other diagnostic agents | 4454 |
| |
| V04CX | Other diagnostic agents Helicobacter Test INFAI (active) | 3830 |
| |
|
|
|
|
|
|
| V08 | Contrast media | 823 |
| |
| V08C | Magnetic resonance imaging contrast media | 1 |
| |
| V08CA | Paramagnetic contrast media | 1 |
| |
| V08CA02 | gadoteric acid Artirem (active) | 0 |
| V08CA05 | mangafodipir Teslascan (withdrawn) | 0 |
| V08CA06 | gadoversetamide Optimark (not renewed) | 0 |
| V08CA08 | gadobenic acid MultiHance (active) | 0 |
| V08CA09 | gadobutrol Gadograf (active) | 1 |
| V08CA11 | gadofosveset Ablavar (withdrawn) | 0 |
|
|
|
|
| V08D | Ultrasound contrast media | 4 |
| |
| V08DA | Ultrasound contrast media | 4 |
| |
| V08DA01 | microspheres of human albumin Optison (active) | 4 |
| V08DA04 | microspheres of phospholipids Luminity (active) | 0 |
| V08DA05 | sulfur hexafluoride SonoVue (active) | 0 |
|
|
|
|
|
|
| V09 | Diagnostic radiopharmaceuticals | 0 |
| |
| V09A | Central nervous system | 0 |
| |
| V09AB | Iodine (123I) compounds | 0 |
| |
| V09AB03 | iodine ioflupane (123I) DaTSCAN (active) | 0 |
|
|
| V09AX | Other central nervous system diagnostic radiopharmaceuticals | 0 |
| |
| V09AX04 | streptoduocin Vizamyl (active) | 0 |
| V09AX05 | florbetapir (18F) Amyvid (active) | 0 |
| V09AX06 | florbetaben (18F) Neuraceq (active) | 0 |
|
|
|
|
| V09H | Inflammation and infection detection | 0 |
| |
| V09HA | Technetium (99mTc) compounds | 0 |
| |
| V09HA03 | technetium (99mTc) antigranulocyte antibody Scintimun (active) | 0 |
| V09HA04 | technetium (99mTc) sulesomab LeukoScan (withdrawn) | 0 |
|
|
|
|
| V09I | Tumour detection | 0 |
| |
| V09IA | Technetium (99mTc) compounds | 0 |
| |
| V09IA01 | technetium (99mTc) antiCarcinoEmbryonicAntigen antibody CEA | 0 |
| V09IA02 | technetium (99mTc) antimelanoma antibody Tecnemab | 0 |
| V09IA05 | technetium (99mTc) depreotide NeoSpect (withdrawn) | 0 |
| V09IA09 | technetium (99mTc) tilmanocept Lymphoseek (active) | 0 |
|
|
| V09IB | Indium (111In) compounds | 0 |
| |
| V09IB03 | indium (111In) antiovariumcarcinoma antibody Indimacis 125 (withdrawn) | 0 |
|
|
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection | 0 |
| |
| V09IX04 | fludeoxyglucose (18F) Gluscan 500 (active) | 0 |
| V09IX09 | gallium (68Ga) edotreotide SomaKit TOC (active) | 0 |
| V09IX12 | fluciclovine (18F) Axumin (active) | 0 |
|
|
|
|
|
|
| V10 | Therapeutic radiopharmaceuticals | 0 |
| |
| V10B | Pain palliation (bone seeking agents) | 0 |
| |
| V10BX | Various pain palliation radiopharmaceuticals | 0 |
| |
| V10BX02 | samarium (153Sm) lexidronam Quadramet (active)fs | 0 |
|
|
|
|
| V10X | Other therapeutic radiopharmaceuticals | 0 |
| |
| V10XX | Various therapeutic radiopharmaceuticals | 0 |
| |
| V10XX02 | ibritumomab tiuxetan Zevalin (active) | 0 |
| V10XX03 | radium (223Ra) dichloride Xofigo (active) | 0 |
| V10XX04 | lutetium (177Lu) oxodotreotide Lutathera (active) | 0 |
|
|
|
|
|
|
|
|
|